Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/20/2019
Four companies reach $260M opioid settlement with Ohio counties
AmerisourceBergen, Cardinal Health, McKesson and Teva have reached a settlement with two Ohio counties over their role in the opioid addiction epidemic. - 10/20/2019
CVS Health, UPS partner on drone delivery
UPS and CVS Health have signed an agreement to explore drone delivery options, which will include delivery of prescriptions and retail products to CVS Pharmacy customers. - 10/20/2019
FDA approves new indication for Janssen’s Stelara
Janssen's Stelara now has Food and Drug Administration approval for six indications, most recently for adults with moderately to severely active ulcerative colitis. - 10/17/2019
FDA approves expanded indication for Roche's Xofluza
Roche’s single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza. - 10/17/2019
McKesson RxOwnership, NCPA sponsor 10th annual Ownership Workshop series
The McKesson RxOwnership Workshop takes place Oct. 24-26, ahead of the NCPA Annual Convention. - 10/17/2019
NACDS recommends pain management, opioid policies in comments to CMS
NACDS said its comments to the Centers for Medicare and Medicaid Services highlights the critical role pharmacists can play.in preventing opioid addiction and enhancing access to medication-assisted treatment. - 10/16/2019
Price Chopper/Market 32 pharmacies connect prescription, immunization data to Hixny
The partnership between Price Chopper/Market 32 and Hixny establishes Hixny's health information exchange as the first in New York to contribute pharmacy information across multiple state borders. - 10/16/2019
Diplomat sells certain assets of Envoy Health Management to Diligent Health Solutions
Diplomat is retaining a portion of the Envoy Health Management operations that specialize in digital therapeutics and pharmaceutical services. - 10/16/2019
Glenmark gets FDA OK for generic Zytiga
Zytiga tablets, 250 mg had a market value of $794.1 million for the 12 month period ended August 2019, according to IQVIA. - 10/15/2019
Sun Pharma launches Drizalma Sprinkle
Sun Pharma’s Drizalma Sprinkle is the first and only FDA approved sprinkle formulation of delayed-release duloxetine capsules.
